Suppliers / Boryung Pharmaceutical

Boryung Pharmaceutical

South Korea Updated 9 July 2026

Boryung Pharmaceutical is an API and finished-dose manufacturer based in South Korea. It holds one valid CEP. Its filings concentrate with DIGEMAPS (DO), JFDA (JO) and NPRA (MY).

0
active US DMFs
1
valid CEPs
1
registered plants
23
filings across 5 regulators

Registered plants

Site FDA FEI
Seoul, South Korea Not on file

What they file, and where

Molecule Regulators Docs
Doxorubicin Hydrochloride EDQM 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 7 None
JFDA (JO) 6 None
NPRA (MY) 5 None
MINSA (CR) 4 None
ARCSA (EC) 1 None

Comparing suppliers?

Choose your molecules and target markets. Boryung Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability